(Q41264910)

28 September 2017

title

Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2. (English)

1 reference

28 September 2017

Hargreaves RE

1

1 reference

28 September 2017

Brehm RD

2

1 reference

28 September 2017

Tranter H

3

1 reference

28 September 2017

Warrens AN

4

1 reference

28 September 2017

Lombardi G

5

1 reference

28 September 2017

Lechler RI

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

European Journal of Immunology

28 September 2017

published in

1 reference

28 September 2017

volume

25

1 reference

28 September 2017

issue

12

1 reference

28 September 2017

page(s)

3437-3444

1 reference

V beta-specific stimulation of human T cells by staphylococcal toxins.

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V gamma 9 region

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

The staphylococcal enterotoxins and their relatives.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Evidence for the effects of a superantigen in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Evidence for a superantigen in human tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Superantigens interact with MHC class II molecules outside of the antigen groove.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Both alpha-helices along the major histocompatibility complex binding cleft are required for staphylococcal enterotoxin A function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

A monoclonal antibody with broad anti-HLA-DR activity fails to bind to DRw11/Dw5: possible effect of a unique polymorphism on the beta 1 domain alpha-helix

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251235

7 January 2021

Identifiers

DOI

10.1002/EJI.1830251235

1 reference

28 September 2017

1 reference